Who has been buying Genomic tree stock?

0 distinct insiders have filed 0 disclosed insider purchases in Genomic tree (228760), most recently on 2026-05-20. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Genomic tree have?

Genomic tree has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-07-03 to 2026-05-20.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Genomic tree 228760

Company

지노믹트리Genomic tree

Insiders

Buys

Total Value

—

Avg Return

—

Last Filing

2026-05-20

Genomic tree (228760) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Genomic tree is dated 2024-07-03; the most recent is 2026-05-20.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-05-20	BUY	자사주상여금	이정철 Lee Jeong-cheol	moving	1.0K	₩13,530	+1.2%	₩14M ($9K)
2026-05-20	BUY	자사주상여금	이홍선 Lee Hong-seon	Managing Director	2.0K	₩13,530	+1.2%	₩27M ($19K)
2026-05-20	BUY	자사주상여금	이용운 Lee Yong-un	Managing Director	2.0K	₩13,530	+1.2%	₩27M ($19K)
2026-05-20	BUY	자사주상여금	오태정 Taejeong Oh	Managing Director	2.0K	₩13,530	+1.2%	₩27M ($19K)
2026-01-08	BUY	자사주상여금	오태정 Taejeong Oh	Managing Director	3.5K	₩28,750	-24.0%	₩101M ($70K)
2026-01-08	BUY	자사주상여금	이정철 Lee Jeong-cheol	moving	1.8K	₩28,750	-24.0%	₩50M ($35K)
2026-01-08	BUY	자사주상여금	이홍선 Lee Hong-seon	Managing Director	3.5K	₩28,750	-24.0%	₩101M ($70K)
2026-01-08	BUY	자사주상여금	이용운 Lee Yong-un	Managing Director	3.5K	₩28,750	-24.0%	₩101M ($70K)
2025-06-11	BUY	자사주상여금	이정철 Lee Jeong-cheol	moving	1.5K	₩13,010	+68.0%	₩20M ($14K)
2025-06-11	BUY	자사주상여금	오태정 Taejeong Oh	Managing Director	3.0K	₩13,010	+68.0%	₩39M ($27K)
2025-06-11	BUY	자사주상여금	이용운 Lee Yong-un	Managing Director	1.5K	₩13,010	+68.0%	₩20M ($14K)
2025-06-11	BUY	자사주상여금	이홍선 Lee Hong-seon	Managing Director	1.5K	₩13,010	+68.0%	₩20M ($14K)
2024-07-03	BUY	자사주상여금	이홍선 Lee Hong-seon	Managing Director	1.5K	₩23,400	-6.6%	₩35M ($24K)
2024-07-03	BUY	자사주상여금	이용운 Lee Yong-un	Managing Director	1.5K	₩23,400	-6.6%	₩35M ($24K)

Frequently asked questions

Who has been buying Genomic tree stock?: 0 distinct insiders have filed 0 disclosed insider purchases in Genomic tree (228760), most recently on 2026-05-20. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Genomic tree have?: Genomic tree has 0 buy-side and 0 sell-side disclosures on record, spanning 2024-07-03 to 2026-05-20.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.